49 completed. 49 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 49 | Completed 49 |
Follow Prostate Cancer: new trials by email Literature Review of Prostate Cancer trials Research Report on Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy flotufolastat (18F), piflufolastat (18F) - Prostate Cancer | Phase 4 | Completed | Blue Earth Diagnostics | 62 | 2024-12-04 | 2026-07-13 |
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy | Phase 4 | Completed | Beth Israel Deaconess Medical Center | 143 | 2021-12-12 | 2024-01-30 |
| Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. Ciprofloxacin, Trimethoprim/Sulfamethoxazole, Fosfomycin - Complication, Infection | Phase 4 | Completed | Radboud University Medical Center | 1538 | 2018-04-03 | 2022-05-10 |
| Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. Leuprorelin Acetate (Eligard® 45 mg). - Prostate Cancer | Phase 4 | Completed | Zodiac Produtos Farmaceuticos S.A. | 48 | 2017-11-14 | 2022-03-31 |
| A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients Leuprolide - Prostate Cancer | Phase 4 | Completed | Astellas Pharma Singapore Pte. Ltd. | 107 | 2017-06-23 | 2024-11-26 |
| Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Deep to Moderate NMB, Moderate to Deep NMB, Rocuronium - Cholecystitis, Endometriosis | Phase 4 | Completed | Stony Brook University | 79 | 2016-12-27 | 2020-04-08 |
| Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Enzalutamide, Flutamide, Androgen deprivation therapy - Prostate Cancer | Phase 4 | Completed | Astellas Pharma Inc | 206 | 2016-11-02 | 2024-12-09 |
| 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases Pamidronate, Denosumab, Zoledronate - Breast Cancer, Prostate Cancer | Phase 4 | Completed | Ottawa Hospital Research Institute | 263 | 2016-08-01 | 2020-12-02 |
| A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer Degarelix - Prostate Cancer | Phase 4 | Completed | Ferring Pharmaceuticals | 230 | 2016-05-01 | 2021-12-15 |
| Preoperative Brimonidine on IOP of Patients Undergoing RALP brimonidine tartrate 0.2%, Carboxymethylcellulose Eye Drops - Prostate Cancer | Phase 4 | Completed | University Health Network, Toronto | 26 | 2016-02-29 | 2018-09-27 |
| Transperineal, MRI-guided, Prostate Biopsy Transperineal, MRI-guided, prostate biopsy, Transrectal prostate biopsy (TRB): - Prostate Cancer | Phase 4 | Completed | University Hospital, Strasbourg, France | 90 | 2015-05-01 | 2025-12-19 |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer CABAZITAXEL XRP6258, PEG-G-CSF, Prednisolone - Prostate Cancer | Phase 4 | Completed | Sanofi | 21 | 2015-04-01 | 2017-01-24 |
| The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide propofol, Desflurane - Prostate Cancer | Phase 4 | Completed | Yonsei University | 50 | 2014-05-01 | 2015-07-29 |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism Triptorelin, Orchiectomy - Prostate Cancer, Metabolic Syndrome | Phase 4 | Completed | Herlev Hospital | 31 | 2014-04-01 | 2015-10-28 |
| Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients Enzalutamide, Abiraterone, Placebo for Enzalutamide - Prostate Cancer | Phase 4 | Completed | Pfizer | 509 | 2013-10-22 | 2023-09-18 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. Triptorelin 11.25 mg - Prostate Cancer | Phase 4 | Completed | Ipsen | 226 | 2012-12-11 | 2020-12-09 |
| The Use of Thermal Suits as Preventing Hypothermia During Surgery Thermal suit, Conventional clothing - Prostate Cancer | Phase 4 | Completed | Tampere University Hospital | 100 | 2012-11-01 | 2017-01-04 |
| Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin - Prostate Cancer | Phase 4 | Completed | Sanofi | 45 | 2012-07-01 | 2016-07-06 |
| Hydroxyethyl Starch and Renal Function After Radical Prostatectomy Voluven (Hydroxyethyl starch 130/0,4), Sodium Chloride 9 mg/ml - Prostate Cancer | Phase 4 | Completed | Regional Hospital Holstebro | 40 | 2012-01-01 | 2013-09-17 |
Showing 20 of 49. Sign in to see all of them.
Prostatic Neoplasms (49) · Breast Neoplasms (3) · Neoplasms (3) · Anxiety Disorders (2) · Pain (2) · Prostatic Hyperplasia (2) · Acromegaly (1) · Bone Diseases, Metabolic (1) · Cholecystitis (1) · Coronary Artery Disease (1) · Dumping Syndrome (1) · Endometriosis (1) · Erectile Dysfunction (1) · Esophageal Diseases (1) · Fatty Liver (1)
Genital Diseases (49) · Genital Diseases, Male (49) · Genital Neoplasms, Male (49) · Male Urogenital Diseases (49) · Neoplasms by Site (49) · Urogenital Neoplasms (49) · Prostatic Diseases (48) · Urogenital Diseases (48) · Neoplasms (46) · Pathological Conditions, Signs and Symptoms (5) · Digestive System Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Bone Diseases (3) · Breast Diseases (3)
Zoledronic Acid (10) · luprolide acetate gel depot (4) · Leuprolide (3) · Triptorelin Pamoate (3) · Ciprofloxacin (2) · Dutasteride (2) · Prednisolone (2) · Prednisone (2) · bicalutamide (2) · cabazitaxel (2) · enzalutamide (2) · Abiraterone Acetate (1) · Amdinocillin Pivoxil (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Androgen Antagonists (1)
Novartis Pharmaceuticals (6) · Novartis (3) · Astellas Pharma Inc (2) · Sanofi (2) · Yonsei University (2) · American Medical Systems (1) · Astellas Pharma Singapore Pte. Ltd. (1) · AstraZeneca (1) · Axogen Corporation (1) · Bay State Clinical Trials, Inc. (1) · Beth Israel Deaconess Medical Center (1) · Blue Earth Diagnostics (1) · Bucheon St. Mary's Hospital (1) · Chesapeake Urology Research Associates (1) · Copenhagen University Hospital, Rigshospitalet (1)
United States (16) · Canada (6) · Denmark (4) · South Korea (4) · Brazil (3) · Finland (3) · France (3) · Germany (3) · Greece (3) · Italy (3) · Japan (3) · Netherlands (3) · Spain (3) · Belgium (2) · India (2)
Anne Sophie P. Kancir, MD PhD (1) · Brian Helfand, M.D. (1) · Buys M Yvonne, MD FRCSC (1) · Byung Ha Chung, Medicine (1) · Carlos Hernandez, MD (1) · Colin McCartney, MD (1) · Evangelos Liatsikos, MD (1) · Gabriel Mena, MD (1) · Goun Roh, MD (1)
PMID 17724727, PMID 19143027, PMID 24354113, PMID 25627076, PMID 27286961, PMID 30028657, PMID 30224019, PMID 30300367, PMID 31329922, PMID 34068083, PMID 35280654, PMID 36419331, PMID 37101774, PMID 40389061, PMID 41729277, PMID 4723349
R01CA138627 (1)